Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Antifibrinolytic MDCO-2010 safe in first-in-patient trial

Oct. 18, 2011

First-in-patient study assesses EMD-525797 in metastatic CRPC

Oct. 18, 2011

Results made available from MENZA trial of enzastaurin

Oct. 18, 2011

Migalastat hydrochloride evaluated in female patients with Fabry's disease

Oct. 17, 2011

Ongoing trial assesses modafinil in postoperative cognitive dysfunction

Oct. 17, 2011

Gene therapy for hemophilia B evaluated in rhesus macaques

Oct. 17, 2011

New clinical data presented on novel HIV integrase inhibitor

Oct. 17, 2011

FOB Synthesis describes new carbapenem with activity against multidrug-resistant bacteria

Oct. 17, 2011

Studies provide overview of data on novel antibacterial LFF-571

Oct. 17, 2011

Phase I trials assess efatutazone in Japanese and Korean patients with advanced solid tumors

Oct. 17, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...